US 11723903
Treatment of schizophrenia
granted A61KA61K31/454A61K9/0024
Quick answer
US patent 11723903 (Treatment of schizophrenia) held by VANDA PHARMACEUTICALS INC. expires Mon Aug 10 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- VANDA PHARMACEUTICALS INC.
- Grant date
- Tue Aug 15 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 10 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K31/454, A61K9/0024